Arbutus Biopharma restructures to cut costs & focus on Hepatitis B drug imdusiran. Read more about ABUS stock here.
MyChesCo on MSN18h
Arbutus Biopharma Reports 2024 Financial Results and Strategic UpdatesArbutus Biopharma Corporation (Nasdaq: ABUS) has announced its financial results for the fourth quarter and fiscal year 2024, ...
The charges follow a recent Newtown Township vandalism of a Cybertruck that potentially mirrors backlash against Elon Musk ...
Daily Star on MSN34m
High street store closures including WHSmith and Poundland – is your local closing?It is feared more than 17,000 stores will shut this year as brands face higher costs from this April going forward, after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback